Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
6.17
+0.02 (0.33%)
Aug 5, 2026, 10:59 AM EDT - Market open
Gyre Therapeutics Employees
Gyre Therapeutics had 625 employees as of December 31, 2025. The number of employees increased by 46 or 7.94% compared to the previous year.
Employees
625
Change (1Y)
46
Growth (1Y)
7.94%
Revenue / Employee
$187,278
Profits / Employee
-$10,179
Market Cap
687.89M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 625 | 46 | 7.94% |
| Dec 31, 2024 | 579 | -14 | -2.36% |
| Dec 31, 2023 | 593 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| Phathom Pharmaceuticals | 371 |
| Rigel Pharmaceuticals | 174 |
| Neurogene | 131 |
| BridgeBio Oncology Therapeutics | 106 |
| CytomX Therapeutics | 69 |
| AgomAb Therapeutics NV | 62 |
| Crescent Biopharma | 55 |
GYRE News
- 19 days ago - Gyre Therapeutics Appoints Three New Members to its Board of Directors - GlobeNewsWire
- 23 days ago - Gyre Therapeutics Registration statement: Registration filing - Filings
- 6 weeks ago - Gyre Therapeutics Registration statement: Registration filing - Filings
- 6 weeks ago - Gyre Therapeutics files to sell 30.22M shares of common stock for holders - TheFly
- 7 weeks ago - Gyre Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - Gyre Therapeutics Slides: Corporate presentation - Filings
- 2 months ago - Kaskela Law LLC Announces Investigation of Gyre Therapeutics, Inc. (GYRE) and Encourages Long-Term GYRE Shareholders to Contact the Firm - Newsfile Corp
- 3 months ago - Gyre Therapeutics announces China NMPA acceptance of F351 NDA - TheFly